Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-14-000196
Filing Date
2014-10-14
Accepted
2014-10-14 13:13:31
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K s100381_10k.htm 10-K 661832
2 EXHIBIT 31.1 s100381_ex31-1.htm EX-31.1 9424
3 EXHIBIT 32.1 s100381_ex32-1.htm EX-32.1 3429
  Complete submission text file 0001615774-14-000196.txt   4987134

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ilns-20140630.xml EX-101.INS 680206
5 XBRL SCHEMA FILE ilns-20140630.xsd EX-101.SCH 51188
6 XBRL CALCULATION FILE ilns-20140630_cal.xml EX-101.CAL 26287
7 XBRL DEFINITION FILE ilns-20140630_def.xml EX-101.DEF 249097
8 XBRL LABEL FILE ilns-20140630_lab.xml EX-101.LAB 330827
9 XBRL PRESENTATION FILE ilns-20140630_pre.xml EX-101.PRE 300770
Mailing Address 550 SYLVAN AVENUE SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201 608-5102
Intellect Neurosciences, Inc. (Filer) CIK: 0001337905 (see all company filings)

EIN.: 208329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55268 | Film No.: 141154596
SIC: 2834 Pharmaceutical Preparations